We are live on ! Find out more
SIA

Sit Investment Associates Portfolio holdings

AUM $4.93B
1-Year Est. Return 12.22%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+12.22%
3 Year Est. Return
+41.16%
5 Year Est. Return
+31.78%
10 Year Est. Return
+136.16%
AUM
$3.83B
AUM Growth
+$145M
Cap. Flow
+$22.9M
Cap. Flow %
0.6%
Top 10 Hldgs %
20.23%
Holding
562
New
28
Increased
137
Reduced
174
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 17.63%
2 Healthcare 7.47%
3 Industrials 6.43%
4 Financials 5.88%
5 Consumer Discretionary 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAG icon
201
Conagra Brands
CAG
$7.02B
$4.57M 0.12%
135,465
-50,835
-27% -$1.83M
MUI
202
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
$4.54M 0.12%
396,653
+189,312
+91% +$2.16M
ALTR
203
DELISTED
Altair Engineering Inc
ALTR
$4.54M 0.12%
59,808
+2,275
+4% +$163K
DMO
204
Western Asset Mortgage Opportunity Fund
DMO
$121M
$4.41M 0.12%
417,062
EEFT icon
205
Euronet Worldwide
EEFT
$2.65B
$4.3M 0.11%
36,600
TREX icon
206
Trex
TREX
$4.99B
$4.18M 0.11%
63,710
MKSI icon
207
MKS Inc
MKSI
$20.1B
$4.15M 0.11%
38,425
EXAS
208
DELISTED
Exact Sciences
EXAS
$4.13M 0.11%
44,025
-725
-2% -$56.6K
ASGI
209
abrdn Global Infrastructure Income Fund
ASGI
$756M
$4.1M 0.11%
230,347
MTN icon
210
Vail Resorts
MTN
$5.19B
$4.05M 0.11%
16,085
CCEP icon
211
Coca-Cola Europacific Partners
CCEP
$46.6B
$3.95M 0.1%
61,300
SPLK
212
DELISTED
Splunk Inc
SPLK
$3.94M 0.1%
37,165
SRPT icon
213
Sarepta Therapeutics
SRPT
$1.85B
$3.93M 0.1%
34,310
+3,525
+11% +$455K
RIV
214
RiverNorth Opportunities Fund
RIV
$316M
$3.93M 0.1%
343,324
-246,298
-42% -$2.75M
DHF
215
BNY Mellon High Yield Strategies Fund
DHF
$172M
$3.92M 0.1%
1,767,000
TECH icon
216
Bio-Techne
TECH
$11.2B
$3.81M 0.1%
46,700
MHD icon
217
BlackRock MuniHoldings Fund
MHD
$606M
$3.74M 0.1%
321,503
-72,245
-18% -$840K
IIM icon
218
Invesco Value Municipal Income Trust
IIM
$596M
$3.73M 0.1%
315,910
-42,258
-12% -$499K
LOGI icon
219
Logitech
LOGI
$14.9B
$3.7M 0.1%
62,258
-400
-0.6% -$24.2K
OLN icon
220
Olin
OLN
$2.16B
$3.68M 0.1%
71,525
DCF
221
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$3.64M 0.1%
482,700
+50,551
+12% +$384K
WEC icon
222
WEC Energy
WEC
$34.5B
$3.56M 0.09%
40,340
JPI
223
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
$3.54M 0.09%
210,782
+46,578
+28% +$785K
HNW
224
DELISTED
Pioneer Diversified High Income Fund
HNW
$3.5M 0.09%
346,874
+35,655
+11% +$357K
GLO
225
Clough Global Opportunities Fund
GLO
$259M
$3.46M 0.09%
690,491
+70,831
+11% +$340K

Similar funds

Sit Investment Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Sit Investment Associates held 562 positions worth $3.83B, up 4% from $3.68B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Sit Investment Associates's Q2 2023 filing shows 28 new, 137 increased, 174 reduced and 16 closed positions. Its largest new stake was ETFMG Sit Ultra Short ETF: 249,300 shares worth $12.1M. The largest sale was Nuveen Ohio Quality Municipal Income Fund, an estimated $16.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Sit Investment Associates's largest Q2 2023 buy was ETFMG Sit Ultra Short ETF: 249,300 shares worth $12.1M.
  • Sit Investment Associates added most to CBRE Global Real Estate Income Fund in Q2 2023, an estimated $49.6M increase.
  • Sit Investment Associates's biggest Q2 2023 reduction was Western Asset Inflation-Linked Opportunities & Income Fund, cutting an estimated $10.7M.
  • Sit Investment Associates fully exited Nuveen Ohio Quality Municipal Income Fund in Q2 2023, selling an estimated $16.7M.
  • Sit Investment Associates's ten largest holdings make up 20% of its $3.83B portfolio in Q2 2023.
  • Sit Investment Associates opened 28 new positions and closed 16 in Q2 2023.
  • Sit Investment Associates's portfolio value rose 4% quarter-over-quarter to $3.83B.

Based on Sit Investment Associates's 13F filing for Q2 2023, filed 10 Aug 2023.